Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00116467
Status:
COMPLETED
Last Update Posted:
2007-12-24
First Post:
2005-06-29
Brief Title:
Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia
Sponsor:
Cell Genesys
Organization:
Cell Genesys
Study Overview
Official Title:
Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia The Use of Autologous Tumor Cells With an Allogeneic GM-CSF Producing Cell Line
Status:
COMPLETED
Status Verified Date:
2007-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate clinical and laboratory safety associated with the administration of GVAX leukemia vaccine and to determine the feasibility of generation of GVAX leukemia vaccine in subjects with acute myelogenous leukemia AML
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| K-0009 | None | None | None |